Cardea Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9640 Towne Centre Dr Ste 100, San Diego,...Phone Number
(619) 630-0703Website
www.cardeabio.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cardea Bio
Cardea has linked computers to the live molecular signals running biology. Its multi-omics technology consists of a Tech+Bio Infrastructure (hardware, software, and wetware) and Chipsets manufactured with proprietary graphene-based, biology-gated transistors, called Cardean Transistors. Cardean Transistors leverage graphene, a nanomaterial that is biocompatible and a near perfect conductor as it is only one atom thick, in contrast to the common semiconductor material, silicon. Cardea thereby gains a signal resolution high enough to listen into molecular signals in a manner that replaces optical and static measurements with interactive live-streams of multi-omic signals and analyses. Cardea is on a long-term mission they call "Linking up to Life" to empower its partners with Tech+Bio solutions that make significant positive impacts on the world via innovative applications that are "Powered by Cardea.Explore more
Cardea Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardea Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cardea Bio
Click to see if Cardea Bio had a recent Job posting/layoffs
Check if Cardea Bio has recently received funding, and reach out quickly before it becomes old news!
Cardea Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cardea Bio has new funding data
Earning: See what the market has to say on Cardea Bio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cardea Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Cardea Bio launches new products
Recommended Actions
Find VP level buyers at Cardea Bio
Find more new buyers
Compare Similar Companies to Cardea Bio
Compare insights from companies similar to Cardea Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cardea Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cardea Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cardea Bio.
Cardea Bio financials insights
Gather financial insights about Cardea Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$1.6M
2016
Debt
$600K
2017
Debt
$550K
2020
Debt
$150K
Other Financing Round
$7.5M
Cardea Bio Tech Stack
A closer look at the technologies used by Cardea Bio
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Mergers & Acquisitions (M&A)
Open Position
Cardea Bio News & Media
Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity
SAN DIEGO--(BUSINESS WIRE)-- #CRISPR--Today, CRISPR QC announces that Paragraf, Ltd. has acquired Cardea Bio, the technology platform developer of the CRISPR-Chip - a graphene-based biosensor that powers CRISPR QC’s CRISPR Analytics Platform. Paragraf is the only company in the world to mass produce graphene electronics using transfer-free graphene and standard semiconductor processes, which ensures a reliable supply of CRISPR-chips for the CRISPR Analytics Platform, enabling it to meet the needUK's graphene device manufacturer Paragraf acquires San Diego’s Cardea Bio
Cambridgeshire UK-based graphene device manufacturer Paragraf has acquired San Diego-based Cardea Bio makers of a graphene biosensor. Cardea Bio has been renamed Paragraf USA and Michael Heltzen CEO a...Dr. Kiana Aran's CRISPR-chip selected for national German exhibition on novel genetic research
SAN DIEGO, April 19, 2023 /PRNewswire/ -- The ongoing exhibition 'Of Genes and Human Beings' at the national German DHMD museum in Dresden, highlights multiple technological advances in the genetic field over the last century and especially the last 20 years. Cardea Bio's BPU variant, the...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardea Bio
Sign Up For FreeTo access detailed company insights
Cardea has linked computers to the live molecular signals running biology. Its multi-omics technology consists of a Tech+Bio Infrastructure (hardware, software, and wetware) and Chipsets manufactured with proprietary graphene-based, biology-gated transistors, called Cardean Transistors. Cardean Transistors leverage graphene, a nanomaterial that is... Read More
